testing cancer drugs

A new study from Finland tested over 500 cancer drugs on malignant pleural mesothelioma (MPM) cells to find new treatments for this aggressive disease. As of this writing, the only FDA approved chemotherapy for MPM is a combination of pemetrexed and cisplatin. Even though this is the most common first-line treatment for MPM, it is not always effective at improving survival. This is why studies that look for new drug treatments are so important. This research can help doctors to find better treatments for MPM in the future. Worldwide Poor Prognosis MPM is a rare cancer caused by asbestos exposure. It affects the membranes around the lungs and can spread to the lungs and elsewhere in the chest. MPM has…